Dr. Atsushi Hayashi, Director of Shonan Aesthetic Dermatology Gotanda, Presents at "Cutting Edge 2026" Aesthetic Medicine Forum
Sharing Insights on the Essence and Clinical Judgment of Lower Eyelid Treatment Through the Re-evaluation of Anatomy from an Injector’s Perspective
IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Dr. Atsushi Hayashi, Director of Shonan Aesthetic Dermatology Gotanda, which operates with management support from the Company, served as a speaker at "Cutting Edge 2026," a practice-oriented forum held in Tokyo from February 9 to 10, 2026.
"Cutting Edge" is a forum dedicated to sharing the "essence" and "judgment" of aesthetic medicine, aimed at refining highly advanced and practical techniques and knowledge. It has garnered significant attention as a venue where industry-leading experts gather to discuss treatment strategies and clinical evidence directly applicable to frontline medical practice.
At "Cutting Edge 2026," Dr. Hayashi presented on a new anatomical approach designed to enhance the safety and effectiveness of injectable treatments, including hyaluronic acid fillers. The lower eyelid area possesses a highly delicate structure, requiring advanced expertise for treatment. Based on extensive clinical data within the SBC Medical Group, Dr. Hayashi redefined the anatomy of the lower eyelid from the perspective of "understanding structures without disrupting tissue" and explained safe, highly reproducible treatment methods that minimize variability among practitioners.
In recent years, as technological innovation accelerates in the field of aesthetic medicine, the importance of sharing specialized knowledge and academic collaboration has increased beyond clinical settings. To meet diversifying needs, it is essential to combine the introduction of cutting-edge technology with a broad perspective and flexible thinking. SBC Medical Group will continue to promote advanced initiatives through participation in forums, academic presentations, and exchanges with research institutions, contributing to the sustainable development of aesthetic medicine.
Overview of Cutting Edge 2026
Venue: TOKYO NODE (Toranomon Hills, Tokyo)
Dates: Monday, February 9 – Tuesday, February 10, 2026
Official Website: https://jihi-cuttingedge.com/
Presentation Title
Observing Anatomy Without Dissection: Redefining the Lower Eyelid from an Injector’s Perspective
About Dr. Atsushi Hayashi
Director of Shonan Aesthetic Dermatology Gotanda. Dr. Hayashi specializes in minimally invasive treatments, with a focus on injectables, providing professional and comprehensive treatment designs tailored to the unique condition and facial balance of each patient. He offers long-term support, addressing age-related changes and concerns through strategic treatment combinations and aging care plans. His goal is to support patients through aesthetic medicine so they can lead brighter, more positive daily lives. For more information on Dr. Hayashi’s professional profile, please visit [here].
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com/
For more insights and updates from SBC Holdings, follow us on LinkedIn
Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department E-mail: ir@sbc-holdings.com
ICR LLC (US Time)
Bill Zima / Managing Partner E-mail: bill.zima@icrinc.com